Delivery Order 36F79722D0165-36C24924N0349
Award Date
3/15/24
Potential Completion Date
4/16/24
Potential Value
$6K
Federal Agency
Veterans Integrated Service Network 9
Awardee
Ardelyx, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
La Vergne, TN 37086, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm-fixed-price delivery order to Ardelyx, Inc., a for-profit pharmaceutical company, to provide the drug XPHOZAH [TENAPANOR] to the Boro VAMC Pharmacy. The $6,048.81 contract, awarded in April 2024, has a completion date of May 2024. The order was placed under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and was not set aside for any socioeconomic category. Ardelyx currently holds two active...
This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Ardelyx, Inc., a for-profit pharmaceutical company, to provide the drug XPHOZAH [TENAPANOR] to VA medical centers. The firm-fixed-price delivery orders, valued at $6,048.81 each, were issued under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Ardelyx currently holds two active Indefinite Delivery Vehicles (IDVs) under the same FSS schedule, enabling the company to...
This federal contract award was issued by the Department of Veterans Affairs (VA) to Ardelyx, Inc., a for-profit pharmaceutical company, for the supply of XPHOZAH (tenapanor), a medication used to treat hyperphosphatemia in chronic kidney disease patients on dialysis. The contract, a $34,284.07 firm-fixed-price delivery order, was awarded on October 1, 2024 under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with a completion date of April 1, 2025. Ardelyx holds multiple...
This is a $351,244.44 firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Actelion Pharmaceuticals US, Inc., a large pharmaceutical manufacturer. The order is for specialty medication, primarily treatments for pulmonary arterial hypertension, which are critical drugs for VA medical centers and other federal healthcare facilities. The contract is placed against Actelion's $105 million Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs...
This $200,163.52 delivery order was awarded to Actelion Pharmaceuticals US, Inc., a for-profit manufacturer of specialty pharmaceutical products, by the Department of Veterans Affairs (VA) Veterans Health Administration. The order was placed against Actelion's existing five-year, $105 million Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), which allows federal agencies to procure pre-negotiated prescription medications. The contract does not have a set-aside...
The U.S. Department of Veterans Affairs (VA) awarded a $27,913.44 firm-fixed price delivery order contract to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical products, to provide emergency pharmaceutical orders. The contract is a delivery order under Takeda's General Services Administration (GSA) Multiple Award Schedule contract for Pharmaceuticals and Drugs. The contract supports the VA's Veterans Health Administration in delivering specialty...
This is a $93,341.96 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the specialty pharmaceutical Tyvaso, which is used to treat pulmonary arterial hypertension. This contract is part of Accredo Health Group's ongoing work supporting the VA's Veterans Integrated Service Network (VISN) 21 with the distribution of specialty medications. The...
This is a delivery order issued by the Department of Veterans Affairs (VA) Veterans Health Administration to United Therapeutics Corp, a small disadvantaged business and manufacturer of pharmaceuticals. The order is for Tyvaso inhalation solution, a pulmonary arterial hypertension treatment, with a firm fixed price of $14,693.62 and a completion date of May 16, 2024. The order is placed against United Therapeutics' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB),...
This is a firm fixed-price delivery order award to Travere Therapeutics, Inc., a biopharmaceutical company, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 21. The contract is for the supply of Travere's specialty pharmaceutical product Filspari 400mg, which is used to treat rare diseases affecting kidney and liver function. The award has a ceiling value of $7,354.26 and a period of performance through September 30, 2024. Travere Therapeutics holds a Federal Supply...
This is a delivery order contract awarded by the Department of Veterans Affairs (VA) to Actelion Pharmaceuticals US, Inc., a for-profit manufacturer of pharmaceutical products. The $70,168.62 contract is for the delivery of specialty medications, including treatments for pulmonary arterial hypertension. It was awarded under Actelion's existing Federal Supply Schedule (FSS-61-IB) contract for Pharmaceuticals and Drugs, as well as a separate $60 million Blanket Purchase Agreement focused on...